Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;17(2):2229-2238.
doi: 10.3892/mmr.2017.8108. Epub 2017 Nov 20.

TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention

Affiliations

TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention

Xiao Yang et al. Mol Med Rep. 2018 Feb.

Abstract

The present study investigated the mechanism underlying Toll-like receptor 4 (TLR4)-mediated stimulation of hypoxia-inducible factor-1α (HIF-1α) activity and its association with reactive oxygen species (ROS) in cervical cancer cells. SiHa cells were cultured and randomized to control, lipopolysaccharide (LPS), methyl-β-cyclodextrin (MβCD)+LPS, ammonium pyrrolidinedithiocarbamate (PDTC)+LPS, ST2825+LPS and small interfering (si) RNA TLR4+LPS treatment groups. Cell proliferation was quantified using an MTT assay, cell cloning was performed using soft agar colony formation and HIF-1α expression was detected by immunocytochemical staining and western blot analyses. Dichloro-dihydro-fluorescein diacetate and lucigenin luminescence assays were used to detect alterations in ROS and nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase content, respectively. Co-localization of TLR4 and HIF-1α was detected by immunofluorescence staining and observed using fluorescence microscopy. Compared with the control group, cell proliferation was enhanced in the LPS-treated group and was not altered in the PDTC+LPS treatment group. Cell proliferation was reduced in all other treatment groups (P<0.05). Compared with the LPS group, cell proliferation decreased in all other groups. Compared with the PDTC+LPS treatment group, cell proliferation significantly decreased when LPS was co-administered with ST2825, siTLR4 and MβCD (P<0.01). Treatment with MβCD+LPS exhibited an increased inhibitory effect on cell activity and proliferation. Compared with the control group, HIF-1α expression was enhanced following treatment with LPS, although it decreased when LPS was co-administered with ST2825, siTLR4 and MβCD (P<0.05). HIF-1α expression decreased following treatment with ST2825, siTLR4, MβCD and PDTC+LPS, compared with treatment with LPS alone. Compared with the PDTC+LPS group, HIF-1α activity decreased when LPS was co-administered with ST2825, siTLR4 and MβCD. NADPH oxidase and ROS levels increased in cells treated with LPS, compared with the control group, at 24 and 12 h following treatment, respectively, and decreased at 12 h when LPS was co-administered with ST2825, siTLR4 and MβCD. There was no difference between the LPS and PDTC+LPS groups with respect to NADPH and ROS levels. Compared with the PDTC+LPS group, NADPH oxidase activity and ROS content decreased when LPS was co-administered with ST2825, siTLR4 and MβCD. NADPH oxidase activity and ROS content were lowest in the MβCD+LPS treatment group, and immunofluorescent staining demonstrated that TLR4 was localized to the cell surface and HIF-1α was primarily localized to the cytoplasm. TLR4 was co-expressed with HIF-1α in cervical cancer cells. The results of the present study suggested that TLR4 signaling primarily promoted HIF-1α activity via activation of lipid rafts/NADPH oxidase redox signaling and may be associated with the initiation and progression of cervical cancer. This promoting effect was stronger in TLR4/lipid rafts/NADPH oxidase pathway than that in TLR4-NF-κB signaling pathway. Therefore, the TLR4/lipid raft-associated redox signal may be a target for therapeutic intervention to prevent the growth of cervical cancer.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
An MTT assay was used to measure cell growth in the groups following 1, 2, 3 and 4 days of treatment. Data are presented as the mean ± standard deviation (n=3). **P<0.01 vs. the control group; #P<0.05, ##P<0.01, vs. the LPS group; &&P<0.01 vs. the PDTC+LPS group. LPS, lipopolysaccharide; si, small interfering RNA; TLR4, Toll-like receptor 4; MβCD, methyl-β-cyclodextrin; PDTC, ammonium pyrrolidinedithiocarbamate.
Figure 2.
Figure 2.
Soft agar colony forming experiment. (A) Images of soft agar plate colony formation for treatment groups following 2 weeks of culture. (B) Quantification of colony numbers. Data are presented as the mean ± standard deviation (n=3). *P<0.05 and **P<0.01 vs. the control group; #P<0.05, ##P<0.01 vs. the LPS group; &P<0.05 and &&P<0.01 vs. the PDTC+LPS group. LPS, lipopolysaccharide; si, small interfering RNA; TLR4, Toll-like receptor 4; MβCD, methyl-β-cyclodextrin; PDTC, ammonium pyrrolidinedithiocarbamate.
Figure 3.
Figure 3.
HIF-1α expression levels. (A) Immunocytochemistry images (magnification, ×100). Positive cells were stained brown-yellow. (B) Western blot analysis of HIF-1α expression levels. (C) Statistical analysis of western blotting. The gel was cut to improve the clarity of the figure, as shown by a dotted line. Data are presented as the mean ± standard deviation (n=3). *P<0.05 and **P<0.01 vs. the control group; #P<0.05, ##P<0.01 vs. the LPS group; &P<0.05 and &&P<0.01 vs. the PDTC+LPS group. LPS, lipopolysaccharide; si, small interfering RNA; TLR4, Toll-like receptor 4; MβCD, methyl-β-cyclodextrin; PDTC, ammonium pyrrolidinedithiocarbamate.
Figure 4.
Figure 4.
Detection of NADPH oxidase activity in treatment groups at 0, 12, 24, 36 and 48 h. *P<0.05 and **P<0.01 vs. the control group at 0, 12, 24, 36 and 48 h. #P<0.05, ##P<0.01 vs. the LPS group at 0, 12, 24, 36 and 48 h. &P<0.05 and &&P<0.01 vs. the PDTC+LPS group at 0, 12, 24, 36 and 48 h. LPS, lipopolysaccharide; si, small interfering RNA; TLR4, Toll-like receptor 4; MβCD, methyl-β-cyclodextrin; PDTC, ammonium pyrrolidinedithiocarbamate; nicotinamide-adenine dinucleotide phosphate; NADPH, nicotinamide-adenine dinucleotide phosphate; RLU, relative light units.
Figure 5.
Figure 5.
ROS fluorescence intensity of each group detected at 0, 12, 24, 36 and 48 h. *P<0.05 and **P<0.01 vs. the control group at 0, 12, 24, 36 and 48 h. ##P<0.01, vs. the LPS group at 0, 12, 24, 36 and 48 h. &&P<0.01 vs. the PDTC+LPS group at 0, 12, 24, 36 and 48 h. LPS, lipopolysaccharide; si, small interfering RNA; TLR4, Toll-like receptor 4; MβCD, methyl-β-cyclodextrin; PDTC, ammonium pyrrolidinedithiocarbamate; ROS, reactive oxygen species.
Figure 6.
Figure 6.
The expression and co-localization of TLR4 and HIF-1α detected by immunofluorescence staining. Green, HIF-1α expression; red, TLR4 expression; blue, nuclei. LPS, lipopolysaccharide; si, small interfering RNA; TLR4, Toll-like receptor 4; MβCD, methyl-β-cyclodextrin; PDTC, ammonium pyrrolidinedithiocarbamate.

Similar articles

Cited by

References

    1. Wei KR, Chen WQ, Zhang SW, Zheng RS, Wang YN, Liang ZH. Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003–2007. Zhonghua Fu Chan Ke Za Zhi. 2012;47:445–451. (In Chinese) - PubMed
    1. Sharma N, Akhade AS, Qadri A. Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells. Innate Immun. 2016;22:238–244. doi: 10.1177/1753425916632305. - DOI - PubMed
    1. Galli R, Starace D, Busà R, Angelini DF, Paone A, De Cesaris P, Filippini A, Sette C, Battistini L, Ziparo E, Riccioli A. TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types. J Immunol. 2010;184:6658–6669. doi: 10.4049/jimmunol.0902401. - DOI - PubMed
    1. Molteni M, Marabella D, Orlandi C, Rossetti C. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. Cancer Lett. 2006;235:75–83. doi: 10.1016/j.canlet.2005.04.006. - DOI - PubMed
    1. MacRedmond R, Greene C, Taggart CC, McElvaney N, O'Neill S. Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide. Respir Res. 2005;6:116. doi: 10.1186/1465-9921-6-116. - DOI - PMC - PubMed

MeSH terms

Substances